Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein
Gamal Eldein Fathy Abd-Ellatef, Elena Gazzano, Ahmed H. El‐Desoky, Ahmed R. Hamed, Joanna Kopecka, Dimas Carolina Belisario, Costanzo Costamagna, Mohamed A. Marie, Sohair R. Fahmy, Abdel‐Hamid Z. Abdel‐Hamid, Chiara Riganti
Topics & Concepts
DoxorubicinEffluxPharmacologyP-glycoproteinTriple-negative breast cancerCancer researchCytotoxicityBreast cancerChemistryBiologyBiochemistryMultiple drug resistanceChemotherapyCancerIn vitroAntibioticsGeneticsDrug Transport and Resistance MechanismsCancer therapeutics and mechanismsEstrogen and related hormone effects